Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD Study

CONCLUSION: ABI and QOL improved after a series of LA sessions in conventional treatment-resistant PAD patients with controlled serum lipoprotein levels. Increased antioxidative capacity and ameliorated endothelial function were observed after the LA treatment.PMID:38569869 | DOI:10.5551/jat.64639

Source: Journal of Atherosclerosis and Thrombosis - April 3, 2024 Category: Cardiology Authors: Eiko Ueda Yoshiyuki Toya Hiromichi Wakui Kohei Ishiga Yuki Kawai Ryu Kobayashi Sho Kinguchi Tomohiko Kanaoka Yusuke Saigusa Taro Mikami Yuichiro Yabuki Motohiko Goda Daisuke Machida Takayuki Fujita Kotaro Haruhara Teruyasu Sugano Kengo Azushima Kouichi Ta Source Type: research